Fangchinoline alleviates the progression of osteoarthritis through the nuclear factor kappa B signaling pathway
Authors:
- 1 February 2025
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 496, 117241
Abstract
No abstract availableKeywords
Funding Information
- Medical Science and Technology Project of Zhejiang Province
- Shaoxing Science Technology Bureau
This publication has 28 references indexed in Scilit:
- Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspectiveJournal of Extracellular Vesicles, 2024
- The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-κB and p38-MAPK pathwayBiomedicine & Pharmacotherapy, 2023
- Management of osteoarthritis: From drug molecules to nano/micromedicinesWIREs Nanomedicine and Nanobiotechnology, 2022
- IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBαActa Pharmaceutica Sinica B, 2021
- Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future OpportunitiesCurrent Rheumatology Reports, 2020
- Fangchinoline supplementation attenuates inflammatory markers in experimental rheumatoid arthritis-induced ratsBiomedicine & Pharmacotherapy, 2019
- Suppression of TGP on myocardial remodeling by regulating the NF-κB pathwayBiomedicine & Pharmacotherapy, 2018
- Palmitate Has Proapoptotic and Proinflammatory Effects on Articular Cartilage and Synergizes With Interleukin‐1Arthritis & Rheumatology, 2014
- Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-agingAgeing Research Reviews, 2008
- Osteoarthritis☆Advanced Drug Delivery Reviews, 2006